Overview

This trial is active, not recruiting.

Condition infection
Sponsor University of Pittsburgh
Start date August 2006
End date November 2016
Trial size 500 participants
Trial identifier NCT00298077, IRB# 0602053

Summary

The study will identify patients with infections commonly observed in transplant recipients, describe the epidemiology of their infection, study the risk factors associated with various infections and examine strategies of early diagnosis and prevention of infection

United States No locations recruiting
Other Countries No locations recruiting

Study Design

Time perspective retrospective

Eligibility Criteria

Male or female participants of any age.

Inclusion Criteria: - Patients who receive medical care at UPMC - Patients who developed infections usually observed in transplant recipients Exclusion: - Patients who do not receive medical care in UPMC Oakland campus

Additional Information

Official title A Retrospective Review of Infections Usually Observed in Transplant Recipients
Principal investigator Eun Kwak, MD
Description The following variables will be followed: time and location of positive cultures, underlying diseases and severity of illness, recent immunomodulative therapies, physical exam findings, previous medical surgical conditions, microbiology and virology culture results, laboratory and radiographical data, antimicrobial usage of onset of infection, microbiological data and resistance patterns, choice of antibiotics once organism identified, suspected source of infection, bacteriological outcomes, laboratory results, demographic information, pathology and histology results, summaries of admissions, discharges, operations, death, medications, clinical outcome gender, height, weight, ethnicity, date of transplant, type of transplant, primary diagnosis, and past medical history. Also required are medical summaries of admissions, discharges, operations, and deaths
Trial information was received from ClinicalTrials.gov and was last updated in December 2015.
Information provided to ClinicalTrials.gov by University of Pittsburgh.